Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Ischemic Heart Disease

  Free Subscription

Articles published in Heart

Retrieve available abstracts of 263 articles:
HTML format

Single Articles

    July 2021
  1. MASSERA D, Hu M, Delaney JA, Bartz TM, et al
    Adverse cardiac mechanics and incident coronary heart disease in the Cardiovascular Health Study.
    Heart. 2021 Jul 13. pii: heartjnl-2021-319296. doi: 10.1136/heartjnl-2021-319296
    PubMed     Abstract available

    June 2021
  2. PHREANER N, Daniels LB
    Sex differences in type 2 myocardial infarction: learning that we still have a lot to learn.
    Heart. 2021 Jun 30. pii: heartjnl-2021-319432. doi: 10.1136/heartjnl-2021-319432

    May 2021
  3. CADER FA, Yancy CW, Banerjee S
    To be, or not to be BAME, in the time of COVID-19: does it matter?
    Heart. 2021;107:692-693.

    April 2021
  4. KIMENAI DM, Lindahl B, Chapman AR, Baron T, et al
    Sex differences in investigations and outcomes among patients with type 2 myocardial infarction.
    Heart. 2021 Apr 20. pii: heartjnl-2021-319118. doi: 10.1136/heartjnl-2021-319118
    PubMed     Abstract available

  5. MCGOVERN L, Cosgrave J
    Axial flow ventricular assist devices in cardiogenic shock complicating acute myocardial infarction.
    Heart. 2021 Apr 2. pii: heartjnl-2020-318226. doi: 10.1136/heartjnl-2020-318226.
    PubMed     Abstract available

    March 2021
    Ticagrelor versus prasugrel for PCI-managed myocardial infarction: the battle of the giants continues.
    Heart. 2021 Mar 19. pii: heartjnl-2020-318872. doi: 10.1136/heartjnl-2020-318872

  7. VENETSANOS D, Traff E, Erlinge D, Hagstrom E, et al
    Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention.
    Heart. 2021 Mar 12. pii: heartjnl-2020-318694. doi: 10.1136/heartjnl-2020-318694
    PubMed     Abstract available

  8. RASHID M, Timmis A, Kinnaird T, Curzen N, et al
    Racial differences in management and outcomes of acute myocardial infarction during COVID-19 pandemic.
    Heart. 2021 Mar 8. pii: heartjnl-2020-318356. doi: 10.1136/heartjnl-2020-318356.
    PubMed     Abstract available

    February 2021
  9. DANCHIN N, Marijon E
    COVID-19 pandemic: preventing hospital myocardial infarction admissions or preventing acute myocardial infarction altogether?
    Heart. 2021 Feb 1. pii: heartjnl-2020-318646. doi: 10.1136/heartjnl-2020-318646.

    January 2021
  10. BOSSARD M, Gao P, Boden W, Steg G, et al
    Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease.
    Heart. 2021 Jan 27. pii: heartjnl-2020-318045. doi: 10.1136/heartjnl-2020-318045
    PubMed     Abstract available

  11. GIANNOPOULOS G, Karageorgiou S, Vrachatis D, Anagnostopoulos I, et al
    A stand-alone structured educational programme after myocardial infarction: a randomised study.
    Heart. 2021 Jan 22. pii: heartjnl-2020-318414. doi: 10.1136/heartjnl-2020-318414
    PubMed     Abstract available

  12. WU J, Hall AS, Gale CP
    Long-term survival benefit of ramipril in patients with acute myocardial infarction complicated by heart failure.
    Heart. 2021 Jan 15. pii: heartjnl-2020-316823. doi: 10.1136/heartjnl-2020-316823
    PubMed     Abstract available

  13. YANDRAPALLI S, Malik A, Pemmasani G, Aronow W, et al
    Sex differences in heart failure hospitalisation risk following acute myocardial infarction.
    Heart. 2021 Jan 11. pii: heartjnl-2020-318306. doi: 10.1136/heartjnl-2020-318306
    PubMed     Abstract available

  14. WU J, Mamas MA, Mohamed MO, Kwok CS, et al
    Place and causes of acute cardiovascular mortality during the COVID-19 pandemic.
    Heart. 2021;107:113-119.
    PubMed     Abstract available

  15. KOK WE
    Too often and too early: the risk of cardiac ischaemia in adult survivors of childhood cancer.
    Heart. 2021;107:6-7.

  16. ONISHI T, Nakano Y, Hirano KI, Nagasawa Y, et al
    Prevalence and clinical outcomes of triglyceride deposit cardiomyovasculopathy among haemodialysis patients.
    Heart. 2021;107:127-134.
    PubMed     Abstract available

    December 2020
  17. DE FILIPPO O, D'Ascenzo F, Deferrari GM
    COVID-19 pandemic and infarctions: another call to reorganise our healthcare systems.
    Heart. 2020;106:1786-1787.

    November 2020
  18. OTTO CM
    Heartbeat: exercise improves quality of life after acute myocardial infarction.
    Heart. 2020;106:1705-1706.

    October 2020
  19. DING Q, Spatz ES, Lipska KJ, Lin H, et al
    Newly diagnosed diabetes and outcomes after acute myocardial infarction in young adults.
    Heart. 2020 Oct 20. pii: heartjnl-2020-317101. doi: 10.1136/heartjnl-2020-317101
    PubMed     Abstract available

  20. DE BACQUER D, van de Luitgaarden IAT, De Smedt D, Vynckier P, et al
    Socioeconomic characteristics of patients with coronary heart disease in relation to their cardiovascular risk profile.
    Heart. 2020 Oct 16. pii: heartjnl-2020-317549. doi: 10.1136/heartjnl-2020-317549
    PubMed     Abstract available

  21. MOHAMMAD MA, Koul S, Olivecrona GK, Gtberg M, et al
    Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic.
    Heart. 2020 Oct 6. pii: heartjnl-2020-317685. doi: 10.1136/heartjnl-2020-317685.
    PubMed     Abstract available

  22. NIJJER SS, Petraco R, Sen S
    Optimal management of acute coronary syndromes in the era of COVID-19.
    Heart. 2020;106:1609-1616.

    September 2020
  23. SONG J, Murugiah K, Hu S, Gao Y, et al
    Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction in China.
    Heart. 2020 Sep 16. pii: heartjnl-2020-317165. doi: 10.1136/heartjnl-2020-317165
    PubMed     Abstract available

  24. STIERMAIER T, Backhaus SJ, Matz J, Koschalka A, et al
    Frequency and prognostic impact of right ventricular involvement in acute myocardial infarction.
    Heart. 2020 Sep 2. pii: heartjnl-2020-317184. doi: 10.1136/heartjnl-2020-317184.
    PubMed     Abstract available

  25. IHSAN J, Khand A, Adlan AM
    Ventricular storm following late presentation acute myocardial infarction.
    Heart. 2020;106:1399-1448.

  26. ROWLAND B, Kunadian V
    Challenges in the management of older patients with acute coronary syndromes in the COVID-19 pandemic.
    Heart. 2020;106:1296-1301.
    PubMed     Abstract available

    August 2020
  27. KWOK CS, Gale CP, Kinnaird T, Curzen N, et al
    Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction.
    Heart. 2020 Aug 31. pii: heartjnl-2020-317650. doi: 10.1136/heartjnl-2020-317650
    PubMed     Abstract available

  28. HURDUS B, Munyombwe T, Dondo TB, Aktaa S, et al
    Association of cardiac rehabilitation and health-related quality of life following acute myocardial infarction.
    Heart. 2020 Aug 21. pii: heartjnl-2020-316920. doi: 10.1136/heartjnl-2020-316920
    PubMed     Abstract available

  29. WALKER S, Cox E, Rothwell B, Berry C, et al
    Cost-effectiveness of cardiovascular imaging for stable coronary heart disease.
    Heart. 2020 Aug 14. pii: heartjnl-2020-316990. doi: 10.1136/heartjnl-2020-316990
    PubMed     Abstract available

  30. ZHANG X, Wang S, Liu J, Wang Y, et al
    D-dimer and the incidence of heart failure and mortality after acute myocardial infarction.
    Heart. 2020 Aug 12. pii: heartjnl-2020-316880. doi: 10.1136/heartjnl-2020-316880
    PubMed     Abstract available

  31. HUBERS SA, Schirger JA, Sangaralingham SJ, Chen Y, et al
    B-type natriuretic peptide and cardiac remodelling after myocardial infarction: a randomised trial.
    Heart. 2020 Aug 3. pii: heartjnl-2020-317182. doi: 10.1136/heartjnl-2020-317182.
    PubMed     Abstract available

  32. LEE KK, Mills NL
    Early rule-out pathways for myocardial infarction: is observational data enough?
    Heart. 2020 Aug 3. pii: heartjnl-2020-317012. doi: 10.1136/heartjnl-2020-317012.

    July 2020
  33. WILLIAMS C, Brown DL
    Effect of random deferral of percutaneous coronary intervention in patients with diabetes and stable ischaemic heart disease.
    Heart. 2020 Jul 21. pii: heartjnl-2019-316432. doi: 10.1136/heartjnl-2019-316432
    PubMed     Abstract available

  34. OTTO CM
    Heartbeat: Rapid rule-out pathways for acute myocardial infarction.
    Heart. 2020;106:951-953.

    June 2020
  35. YIN X, He Y, Zhang J, Song F, et al
    Patient-level and system-level barriers associated with treatment delays for ST elevation myocardial infarction in China.
    Heart. 2020 Jun 24. pii: heartjnl-2020-316621. doi: 10.1136/heartjnl-2020-316621
    PubMed     Abstract available

  36. NAZIR MS, Mittal TK, Weir-McCall J, Nieman K, et al
    Opportunities and challenges of implementing computed tomography fractional flow reserve into clinical practice.
    Heart. 2020 Jun 19. pii: heartjnl-2019-315607. doi: 10.1136/heartjnl-2019-315607
    PubMed     Abstract available

  37. HOOLE SP, Bambrough P
    Recent advances in percutaneous coronary intervention.
    Heart. 2020 Jun 10. pii: heartjnl-2019-315707. doi: 10.1136/heartjnl-2019-315707
    PubMed     Abstract available

    The comorbid patient: does your heart sink?
    Heart. 2020;106:790.

  39. ALKHALIL M, Spence MS, Owens C
    Ischaemic changes during transcatheter aortic valve implantation.
    Heart. 2020;106:801-866.

  40. CROWE F, Zemedikun DT, Okoth K, Adderley NJ, et al
    Comorbidity phenotypes and risk of mortality in patients with ischaemic heart disease in the UK.
    Heart. 2020;106:810-816.
    PubMed     Abstract available

    May 2020
  41. KEULARDS DCJ, Fournier S, van 't Veer M, Colaiori I, et al
    Computed tomographic myocardial mass compared with invasive myocardial perfusion measurement.
    Heart. 2020 May 29. pii: heartjnl-2020-316689. doi: 10.1136/heartjnl-2020-316689
    PubMed     Abstract available

  42. VAGO H, Szabo L, Dohy Z, Czimbalmos C, et al
    Early cardiac magnetic resonance imaging in troponin-positive acute chest pain and non-obstructed coronary arteries.
    Heart. 2020 May 23. pii: heartjnl-2019-316295. doi: 10.1136/heartjnl-2019-316295
    PubMed     Abstract available

  43. AHMADVAZIR S, Pradhan J, Khattar RS, Senior R, et al
    Sex-based impact of carotid plaque in patients with chest pain undergoing stress echocardiography.
    Heart. 2020 May 22. pii: heartjnl-2019-316507. doi: 10.1136/heartjnl-2019-316507
    PubMed     Abstract available

  44. KOO CY, Aung AT, Chen Z, Kristanto W, et al
    Sleep apnoea and cardiovascular outcomes after coronary artery bypass grafting.
    Heart. 2020 May 18. pii: heartjnl-2019-316118. doi: 10.1136/heartjnl-2019-316118
    PubMed     Abstract available

    Tub bathing and heart disease.
    Heart. 2020;106:710.

  46. NEUMANN JT, Twerenbold R
    How do comorbidities influence troponin concentrations?
    Heart. 2020;106:634-635.

  47. BING R, Mitchell AJ, Newby DE
    Chest pain: when in doubt....
    Heart. 2020;106:690-706.

    April 2020
  48. CHAPMAN AR, Mills NL
    High-sensitivity cardiac troponin and the early rule out of myocardial infarction: time for action.
    Heart. 2020 Apr 27. pii: heartjnl-2020-316811. doi: 10.1136/heartjnl-2020-316811

  49. CHIANG CH, Chiang CH, Lee GH, Gi WT, et al
    Safety and efficacy of the European Society of Cardiology 0/1-hour algorithm for diagnosis of myocardial infarction: systematic review and meta-analysis.
    Heart. 2020 Apr 3. pii: heartjnl-2019-316343. doi: 10.1136/heartjnl-2019-316343.
    PubMed     Abstract available

  50. ADAMSON PD, Mills NL, Newby DE, Troughton RW, et al
    Response to: 'Convalescent troponin and cardiovascular death following acute coronary syndrome' by Kawada.
    Heart. 2020;106:545-546.

  51. KAWADA T
    Convalescent troponin and cardiovascular death in patients with acute coronary syndrome.
    Heart. 2020;106:545.

    Walking the tightrope: cardiovascular risk prediction in patients after acute coronary syndrome.
    Heart. 2020;106:484-486.

  53. MEHILLI J, Presbitero P
    Coronary artery disease and acute coronary syndrome in women.
    Heart. 2020;106:487-492.
    PubMed     Abstract available

  54. POPPE KK, Doughty RN, Wells S, Wu B, et al
    Development and validation of a cardiovascular risk score for patients in the community after acute coronary syndrome.
    Heart. 2020;106:506-511.
    PubMed     Abstract available

  55. PARKINSON J, Minton J, Bouttell J, Lewsey J, et al
    Do age, period or cohort effects explain circulatory disease mortality trends, Scotland 1974-2015?
    Heart. 2020;106:584-589.
    PubMed     Abstract available

    March 2020
  56. KRISAI P, Blum S, Aeschbacher S, Beer JH, et al
    Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation.
    Heart. 2020 Mar 31. pii: heartjnl-2019-316314. doi: 10.1136/heartjnl-2019-316314
    PubMed     Abstract available

  57. UKAI T, Iso H, Yamagishi K, Saito I, et al
    Habitual tub bathing and risks of incident coronary heart disease and stroke.
    Heart. 2020 Mar 24. pii: heartjnl-2019-315752. doi: 10.1136/heartjnl-2019-315752
    PubMed     Abstract available

  58. WALD DS, Casey-Gillman O, Comer K, Mansell JS, et al
    Animation-supported consent for urgent angiography and angioplasty: a service improvement initiative.
    Heart. 2020 Mar 10. pii: heartjnl-2019-316227. doi: 10.1136/heartjnl-2019-316227
    PubMed     Abstract available

  59. QIN Y, Wei X, Han H, Wen Y, et al
    Association between age and readmission after percutaneous coronary intervention for acute myocardial infarction.
    Heart. 2020 Mar 6. pii: heartjnl-2019-316103. doi: 10.1136/heartjnl-2019-316103.
    PubMed     Abstract available

  60. CAMPO G, Tonet E, Chiaranda G, Sella G, et al
    Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial.
    Heart. 2020 Mar 6. pii: heartjnl-2019-316349. doi: 10.1136/heartjnl-2019-316349.
    PubMed     Abstract available

    Can we improve the appropriateness of PCI?
    Heart. 2020;106:405-406.

  62. FORD TJ, Berry C
    Angina: contemporary diagnosis and management.
    Heart. 2020;106:387-398.

  63. MOSS AJ, Jordan A, Carpenter JP
    Seventy-one-year-old man with transient left bundle branch block.
    Heart. 2020;106:386-398.

  64. CAULDWELL M, Steer PJ, von Klemperer K, Kaler M, et al
    Maternal and neonatal outcomes in women with history of coronary artery disease.
    Heart. 2020;106:380-386.
    PubMed     Abstract available

    February 2020
  65. CLARSON LE, Bajpai R, Whittle R, Belcher J, et al
    Interstitial lung disease is a risk factor for ischaemic heart disease and myocardial infarction.
    Heart. 2020 Feb 29. pii: heartjnl-2019-315511. doi: 10.1136/heartjnl-2019-315511
    PubMed     Abstract available

  66. IHDAYHID AR, Sapontis J
    The fractional flow reserve grey zone: a blueprint for the future of coronary revascularisation.
    Heart. 2020 Feb 29. pii: heartjnl-2019-316435. doi: 10.1136/heartjnl-2019-316435

  67. HENNIGAN B, Berry C, Collison D, Corcoran D, et al
    Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial.
    Heart. 2020 Feb 29. pii: heartjnl-2019-316075. doi: 10.1136/heartjnl-2019-316075
    PubMed     Abstract available

  68. JORTVEIT J, Pripp AH, Langorgen J, Halvorsen S, et al
    Incidence, risk factors and outcome of young patients with myocardial infarction.
    Heart. 2020 Feb 28. pii: heartjnl-2019-316067. doi: 10.1136/heartjnl-2019-316067
    PubMed     Abstract available

  69. SUNDARAM V, Rothnie K, Bloom C, Zakeri R, et al
    Impact of comorbidities on peak troponin levels and mortality in acute myocardial infarction.
    Heart. 2020 Feb 26. pii: heartjnl-2019-315844. doi: 10.1136/heartjnl-2019-315844
    PubMed     Abstract available

  70. LUPERCIO F, Giancaterino S, Villablanca PA, Han F, et al
    P2Y12 inhibitors with oral anticoagulation for percutaneous coronary intervention with atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2020 Feb 7. pii: heartjnl-2019-315963. doi: 10.1136/heartjnl-2019-315963.
    PubMed     Abstract available

  71. SHAW JA, Warren J
    Acute coronary syndromes: a success story but still a long way to go.
    Heart. 2020;106:172-173.

  72. OTTO CM
    Heartbeat: When should patients consider implantable cardiac defibrillator deactivation?
    Heart. 2020;106:165-167.

  73. WANG TKM, Grey C, Jiang Y, Jackson RT, et al
    Nationwide trends in acute coronary syndrome by subtype in New Zealand 2006-2016.
    Heart. 2020;106:221-227.
    PubMed     Abstract available

  74. MARIATHAS M, Curzen N
    Use of troponins in clinical practice: Evidence against the use of troponins in clinical practice.
    Heart. 2020;106:251-252.

  75. COLLINSON PO, Apple F, Jaffe AS
    Use of troponins in clinical practice: Evidence in favour of use of troponins in clinical practice: Evidence in favour of use of troponins in clinical practice.
    Heart. 2020;106:253-255.

  76. LITWIN SE, Coles A, Hill CL, Alhanti B, et al
    Discordances between predicted and actual risk in obese patients with suspected cardiac ischaemia.
    Heart. 2020;106:273-279.
    PubMed     Abstract available

  77. SANTIAGO DE ARAUJO PIO C, Chaves G, Davies P, Taylor R, et al
    Cochrane corner: increasing patient utilisation of cardiac rehabilitation.
    Heart. 2020;106:248-250.

    January 2020
  78. MACKAY M
    Sex disparities in acute coronary syndrome care: time to move from understanding to action.
    Heart. 2020;106:92-93.

  79. JOSHI SS, Hamra M, Newby DE
    Diagnostic computed tomography in acute interscapular pain.
    Heart. 2020;106:126-163.
    PubMed     Abstract available

  80. OTTO CM
    Heartbeat: time for action to eliminate sex disparities in management and outcomes of patients with an acute coronary syndrome.
    Heart. 2020;106:89-91.

  81. OTTO CM
    Heartbeat: reducing inequities in cardiovascular disease mortality.
    Heart. 2020;106:1-2.

  82. MNATZAGANIAN G, Hiller JE, Braitberg G, Kingsley M, et al
    Sex disparities in the assessment and outcomes of chest pain presentations in emergency departments.
    Heart. 2020;106:111-118.
    PubMed     Abstract available

  83. HEBER S, Fischer B, Sallaberger-Lehner M, Hausharter M, et al
    Effects of high-intensity interval training on platelet function in cardiac rehabilitation: a randomised controlled trial.
    Heart. 2020;106:69-79.
    PubMed     Abstract available

    December 2019
  84. YANG JX, Stevenson MJ, Valsdottir L, Ho K, et al
    Association between procedure appropriateness and patient-reported outcomes after percutaneous coronary intervention.
    Heart. 2019 Dec 19. pii: heartjnl-2019-315835. doi: 10.1136/heartjnl-2019-315835
    PubMed     Abstract available

  85. BEANE A, Ranasinghe WG, Vithanage TDP, Priyadarshani GDD, et al
    Quality evaluation and future priorities for delivering acute myocardial infarction care in Sri Lanka.
    Heart. 2019 Dec 16. pii: heartjnl-2019-315396. doi: 10.1136/heartjnl-2019-315396
    PubMed     Abstract available

  86. MARCOLINO MS, Ribeiro AL
    Focusing on prehospital care to improve ST elevation myocardial infarction care.
    Heart. 2019 Dec 12. pii: heartjnl-2019-315475. doi: 10.1136/heartjnl-2019-315475

    November 2019
  87. DONDO TB, Hall M, Munyombwe T, Wilkinson C, et al
    A nationwide causal mediation analysis of survival following ST-elevation myocardial infarction.
    Heart. 2019 Nov 15. pii: heartjnl-2019-315760. doi: 10.1136/heartjnl-2019-315760
    PubMed     Abstract available

  88. DOLL JA
    Quality of life after myocardial infarction: more PROgress needed.
    Heart. 2019 Nov 7. pii: heartjnl-2019-315871. doi: 10.1136/heartjnl-2019-315871.

  89. MUNYOMBWE T, Hall M, Dondo TB, Alabas OA, et al
    Quality of life trajectories in survivors of acute myocardial infarction: a national longitudinal study.
    Heart. 2019 Nov 7. pii: heartjnl-2019-315510. doi: 10.1136/heartjnl-2019-315510.
    PubMed     Abstract available

  90. OTTO CM
    Heartbeat: guidelines versus reality for patients with severe aortic stenosis.
    Heart. 2019;105:1683-1685.

  91. OTTO CM
    Heartbeat: sex differences in patient-reported outcomes with atrial fibrillation.
    Heart. 2019;105:1607-1609.

    October 2019
  92. YU CW
    Does thrombectomy inhibit effect of ischaemic postconditioning in STEMI? True or not?
    Heart. 2019 Oct 14. pii: heartjnl-2019-315389. doi: 10.1136/heartjnl-2019-315389

    July 2019
  93. RAHMAN H, Corcoran D, Aetesam-Ur-Rahman M, Hoole SP, et al
    Diagnosis of patients with angina and non-obstructive coronary disease in the catheter laboratory.
    Heart. 2019 Jul 31. pii: heartjnl-2019-315042. doi: 10.1136/heartjnl-2019-315042
    PubMed     Abstract available

  94. LEE CMY, Mnatzaganian G, Woodward M, Chow CK, et al
    Sex disparities in the management of coronary heart disease in general practices in Australia.
    Heart. 2019 Jul 23. pii: heartjnl-2019-315134. doi: 10.1136/heartjnl-2019-315134
    PubMed     Abstract available

  95. NEPPER-CHRISTENSEN L, Hofsten DE, Helqvist S, Lassen JF, et al
    Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction.
    Heart. 2019 Jul 17. pii: heartjnl-2019-314952. doi: 10.1136/heartjnl-2019-314952
    PubMed     Abstract available

  96. BOSSON N
    Telemedicine to improve outcomes for patients with acute myocardial infarction.
    Heart. 2019 Jul 11. pii: heartjnl-2019-315278. doi: 10.1136/heartjnl-2019-315278

  97. Correction: Social isolation and loneliness as risk factors for myocardial infarction, stroke and mortality: UK Biobank cohort study of 479 054 men and women.
    Heart. 2019;105:e8.

    June 2019
  98. MARCOLINO MS, Maia LM, Oliveira JAQ, Melo LDR, et al
    Impact of telemedicine interventions on mortality in patients with acute myocardial infarction: a systematic review and meta-analysis.
    Heart. 2019 Jun 28. pii: heartjnl-2018-314539. doi: 10.1136/heartjnl-2018-314539
    PubMed     Abstract available

  99. ALRAWASHDEH A, Nehme Z, Williams B, Stub D, et al
    Emergency medical service delays in ST-elevation myocardial infarction: a meta-analysis.
    Heart. 2019 Jun 28. pii: heartjnl-2019-315034. doi: 10.1136/heartjnl-2019-315034
    PubMed     Abstract available

  100. GLASS G, O'Connor R, Brady WJ
    Useful addition to acute myocardial infarction diagnosis in patients with left bundle branch block: an algorithm using electrocardiographic and biomarker analysis.
    Heart. 2019 Jun 27. pii: heartjnl-2019-315380. doi: 10.1136/heartjnl-2019-315380

  101. MALIK AH, Yandrapalli S, Aronow WS, Panza JA, et al
    Oral anticoagulants in atrial fibrillation with valvular heart disease and bioprosthetic heart valves.
    Heart. 2019 Jun 14. pii: heartjnl-2019-314767. doi: 10.1136/heartjnl-2019-314767
    PubMed     Abstract available

  102. VINCENT LL, Carlson SD, Krieger EV
    "Unstable angina" in a man aged 53 years.
    Heart. 2019 Jun 1. pii: heartjnl-2018-314651. doi: 10.1136/heartjnl-2018-314651.

    May 2019
  103. NESTELBERGER T, Cullen L, Lindahl B, Reichlin T, et al
    Diagnosis of acute myocardial infarction in the presence of left bundle branch block.
    Heart. 2019 May 29. pii: heartjnl-2018-314673. doi: 10.1136/heartjnl-2018-314673
    PubMed     Abstract available

  104. AL'AREF SJ, Min JK
    Cardiac CT: current practice and emerging applications.
    Heart. 2019 May 29. pii: heartjnl-2018-314229. doi: 10.1136/heartjnl-2018-314229

  105. MATIC DM, Asanin MR, Vukcevic VD, Mehmedbegovic ZH, et al
    Impact on long-term mortality of access and non-access site bleeding after primary percutaneous coronary intervention.
    Heart. 2019 May 25. pii: heartjnl-2019-314728. doi: 10.1136/heartjnl-2019-314728
    PubMed     Abstract available

  106. DARMON A, Ducrocq G
    Ischaemic and bleeding risk assessment after myocardial infarction: combination is the key.
    Heart. 2019 May 4. pii: heartjnl-2019-315050. doi: 10.1136/heartjnl-2019-315050.

  107. LINDHOLM D, Sarno G, Erlinge D, Svennblad B, et al
    Combined association of key risk factors on ischaemic outcomes and bleeding in patients with myocardial infarction.
    Heart. 2019 May 4. pii: heartjnl-2018-314590. doi: 10.1136/heartjnl-2018-314590.
    PubMed     Abstract available

    April 2019
  108. PUELACHER C, Gugala M, Adamson PD, Shah A, et al
    Incidence and outcomes of unstable angina compared with non-ST-elevation myocardial infarction.
    Heart. 2019 Apr 24. pii: heartjnl-2018-314305. doi: 10.1136/heartjnl-2018-314305
    PubMed     Abstract available

  109. KOSHY AN, Ha FJ, Gow PJ, Han HC, et al
    Computed tomographic coronary angiography in risk stratification prior to non-cardiac surgery: a systematic review and meta-analysis.
    Heart. 2019 Apr 24. pii: heartjnl-2018-314649. doi: 10.1136/heartjnl-2018-314649
    PubMed     Abstract available

  110. BEGGS SAS, Rorth R, Gardner RS, McMurray JJV, et al
    Anticoagulation therapy in heart failure and sinus rhythm: a systematic review and meta-analysis.
    Heart. 2019 Apr 8. pii: heartjnl-2018-314381. doi: 10.1136/heartjnl-2018-314381.
    PubMed     Abstract available

  111. NEDKOFF L, Goldacre R, Greenland M, Goldacre MJ, et al
    Comparative trends in coronary heart disease subgroup hospitalisation rates in England and Australia.
    Heart. 2019 Apr 4. pii: heartjnl-2018-314512. doi: 10.1136/heartjnl-2018-314512.
    PubMed     Abstract available

  112. BHATIA S, Anstine C, Jaffe AS, Gersh BJ, et al
    Cardiac magnetic resonance in patients with elevated troponin and normal coronary angiography.
    Heart. 2019 Apr 4. pii: heartjnl-2018-314631. doi: 10.1136/heartjnl-2018-314631.
    PubMed     Abstract available

  113. OTTO CM
    Heartbeat: Improving acute myocardial infarction outcomes in women.
    Heart. 2019;105:501-502.

  114. WEI J, Henry TD, Bairey Merz CN
    Biology and bias: do we have the will to improve cardiovascular disease outcomes for women?
    Heart. 2019;105:503-505.

  115. NEUMANN JT, Westermann D
    More evidence for high-sensitivity troponin assays.
    Heart. 2019;105:587-588.

  116. CHAPMAN AR, Fujisawa T, Lee KK, Andrews JP, et al
    Novel high-sensitivity cardiac troponin I assay in patients with suspected acute coronary syndrome.
    Heart. 2019;105:616-622.
    PubMed     Abstract available

  117. GALLAGHER C, Hendriks JM, Giles L, Karnon J, et al
    Increasing trends in hospitalisations due to atrial fibrillation in Australia from 1993 to 2013.
    Heart. 2019 Apr 1. pii: heartjnl-2018-314471. doi: 10.1136/heartjnl-2018-314471.
    PubMed     Abstract available

    March 2019
  118. SILAROVA B, Sharp S, Usher-Smith JA, Lucas J, et al
    Effect of communicating phenotypic and genetic risk of coronary heart disease alongside web-based lifestyle advice: the INFORM Randomised Controlled Trial.
    Heart. 2019 Mar 30. pii: heartjnl-2018-314211. doi: 10.1136/heartjnl-2018-314211
    PubMed     Abstract available

  119. BROBERG K
    New light on exposure to chemicals and cardiovascular diseases.
    Heart. 2019;105:426.

    Acute mitral regurgitation.
    Heart. 2019 Mar 1. pii: heartjnl-2018-313373. doi: 10.1136/heartjnl-2018-313373.
    PubMed     Abstract available

  121. GUNN J, Taggart DP
    Transcatheter versus surgical intervention: lessons from trials of coronary revascularisation.
    Heart. 2019;105.
    PubMed     Abstract available

    February 2019
  122. MACTIER I, Dalzell JR, Carrick D
    Recurrent myocardial infarction in a 50-year-old woman.
    Heart. 2019 Feb 14. pii: heartjnl-2018-314114. doi: 10.1136/heartjnl-2018-314114
    PubMed     Abstract available

  123. LOGANATH K, Shambrook J, Moss AJ
    A 49-year-old with chest pain and bioprosthetic aortic valve.
    Heart. 2019 Feb 5. pii: heartjnl-2018-314468. doi: 10.1136/heartjnl-2018-314468.
    PubMed     Abstract available

    Cochrane corner: inotropic agents and vasodilator strategies for cardiogenic shock or low cardiac output syndrome.
    Heart. 2019;105:178-179.

  125. CAULDWELL M, Baris L, Roos-Hesselink JW, Johnson MR, et al
    Ischaemic heart disease and pregnancy.
    Heart. 2019;105:189-195.
    PubMed     Abstract available

  126. Correction: Invasive measurement of coronary microvascular resistance in patients with acute myocardial infarction treated by primary PCI.
    Heart. 2019;105:e2.

    January 2019
  127. ZUSMAN O, Bebb O, Hall M, Dondo TB, et al
    International comparison of acute myocardial infarction care and outcomes using quality indicators.
    Heart. 2019 Jan 30. pii: heartjnl-2018-314197. doi: 10.1136/heartjnl-2018-314197
    PubMed     Abstract available

  128. HUO X, Khera R, Zhang L, Herrin J, et al
    Education level and outcomes after acute myocardial infarction in China.
    Heart. 2019 Jan 19. pii: heartjnl-2018-313752. doi: 10.1136/heartjnl-2018-313752
    PubMed     Abstract available

  129. DAVENPORT ED, Syburra T, Gray G, Rienks R, et al
    Management of established coronary artery disease in aircrew with previous myocardial infarction or revascularisation.
    Heart. 2019;105.
    PubMed     Abstract available

  130. DAVENPORT ED, Gray G, Rienks R, Bron D, et al
    Management of established coronary artery disease in aircrew without myocardial infarction or revascularisation.
    Heart. 2019;105.
    PubMed     Abstract available

  131. MADDISON R, Rawstorn JC, Stewart RAH, Benatar J, et al
    Effects and costs of real-time cardiac telerehabilitation: randomised controlled non-inferiority trial.
    Heart. 2019;105:122-129.
    PubMed     Abstract available

  132. MAZLAN-KEPLI W, Dawson J, Berry C, Walters M, et al
    Cessation of dual antiplatelet therapy and cardiovascular events following acute coronary syndrome.
    Heart. 2019;105:67-74.
    PubMed     Abstract available

    December 2018
  133. DU FAY DE LAVALLAZ J, Puelacher C, Lurati Buse G, Bolliger D, et al
    Daytime variation of perioperative myocardial injury in non-cardiac surgery and effect on outcome.
    Heart. 2018 Dec 12. pii: heartjnl-2018-313876. doi: 10.1136/heartjnl-2018-313876
    PubMed     Abstract available

  134. FEINBERG J, Nielsen EE, Gluud C, Jakobsen JC, et al
    Cochrane Corner: drug-eluting stents versus bare-metal stents for acute coronary syndrome.
    Heart. 2018;104:1895-1897.

  135. SLUIJTERS OJJ, Bhatti RM
    Considering lung fibrosis in the context of radiation-induced coronary artery disease.
    Heart. 2018;104:2077-2078.

    Triple antithrombotic therapy after ACS and PCI in patients on chronic oral anticoagulation: update.
    Heart. 2018;104:1976-1983.

    November 2018
  137. MEHTA PK, Beltrame JF
    Myocardial infarction with non-obstructive coronary arteries: a humbling diagnosis in 2018.
    Heart. 2018 Nov 27. pii: heartjnl-2018-314012. doi: 10.1136/heartjnl-2018-314012

  138. WILKINSON C, Bebb O, Dondo TB, Munyombwe T, et al
    Sex differences in quality indicator attainment for myocardial infarction: a nationwide cohort study.
    Heart. 2018 Nov 23. pii: heartjnl-2018-313959. doi: 10.1136/heartjnl-2018-313959
    PubMed     Abstract available

  139. TIMMIS A, Raharja A, Archbold RA, Mathur A, et al
    Validity of inducible ischaemia as a surrogate for adverse outcomes in stable coronary artery disease.
    Heart. 2018;104:1733-1738.
    PubMed     Abstract available

    October 2018
  140. PALM P, Zwisler AO, Svendsen JH, Thygesen LC, et al
    Sexual rehabilitation for cardiac patients with erectile dysfunction: a randomised clinical trial.
    Heart. 2018 Oct 31. pii: heartjnl-2018-313778. doi: 10.1136/heartjnl-2018-313778
    PubMed     Abstract available

  141. KOENRAADT WMC, Siebelink HJ, Bartelings MM, Schalij MJ, et al
    Coronary anatomy in Turner syndrome versus patients with isolated bicuspid aortic valves.
    Heart. 2018 Oct 27. pii: heartjnl-2018-313724. doi: 10.1136/heartjnl-2018-313724
    PubMed     Abstract available

  142. TESTORI C, Beitzke D, Mangold A, Sterz F, et al
    Out-of-hospital initiation of hypothermia in ST-segment elevation myocardial infarction: a randomised trial.
    Heart. 2018 Oct 25. pii: heartjnl-2018-313705. doi: 10.1136/heartjnl-2018-313705
    PubMed     Abstract available

  143. AL RIFAI M, Blaha MJ, Rahman F, Ehrman JK, et al
    Inverse association of pulse pressure augmentation during exercise with heart failure and death.
    Heart. 2018 Oct 25. pii: heartjnl-2018-313736. doi: 10.1136/heartjnl-2018-313736
    PubMed     Abstract available

  144. OTTO CM
    Heartbeat: improving outcomes after myocardial infarction.
    Heart. 2018;104:1553-1554.

  145. ONWORDI ENC, Parker WA, Storey RF
    Dual antiplatelet therapy in the 'real world'.
    Heart. 2018;104:1555-1556.

  146. MANCIO J, Oikonomou EK, Antoniades C
    Perivascular adipose tissue and coronary atherosclerosis.
    Heart. 2018;104:1654-1662.
    PubMed     Abstract available

  147. CUOMO JR, Javaheri SP, Sharma GK, Kapoor D, et al
    How to prevent and manage radiation-induced coronary artery disease.
    Heart. 2018;104:1647-1653.
    PubMed     Abstract available

  148. KAASENBROOD L, Ray KK, Boekholdt SM, Smulders YM, et al
    Estimated individual lifetime benefit from PCSK9 inhibition in statin-treated patients with coronary artery disease.
    Heart. 2018;104:1699-1705.
    PubMed     Abstract available

  149. YNDIGEGN T, Hofmann R, Jernberg T, Gale CP, et al
    Registry-based randomised clinical trial: efficient evaluation of generic pharmacotherapies in the contemporary era.
    Heart. 2018;104:1562-1567.
    PubMed     Abstract available

    September 2018
  150. NASCIMENTO BR, Brant LCC, Marino BCA, Passaglia LG, et al
    Implementing myocardial infarction systems of care in low/middle-income countries.
    Heart. 2018 Sep 29. pii: heartjnl-2018-313398. doi: 10.1136/heartjnl-2018-313398
    PubMed     Abstract available

  151. WILLIAMS MJA, Barr PR, Lee M, Poppe KK, et al
    Outcome after myocardial infarction without obstructive coronary artery disease.
    Heart. 2018 Sep 29. pii: heartjnl-2018-313665. doi: 10.1136/heartjnl-2018-313665
    PubMed     Abstract available

  152. AL-LAMEE RK, Nowbar AN, Francis DP
    Percutaneous coronary intervention for stable coronary artery disease.
    Heart. 2018 Sep 21. pii: heartjnl-2017-312755. doi: 10.1136/heartjnl-2017-312755
    PubMed     Abstract available

  153. KWOK CS, Walsh MN, Volgman A, Alasnag M, et al
    Discharge against medical advice after hospitalisation for acute myocardial infarction.
    Heart. 2018 Sep 12. pii: heartjnl-2018-313671. doi: 10.1136/heartjnl-2018-313671
    PubMed     Abstract available

  154. LEE SE, Lee HY, Cho HJ, Choe WS, et al
    Coronary artery bypass graft versus percutaneous coronary intervention in acute heart failure.
    Heart. 2018 Sep 12. pii: heartjnl-2018-313242. doi: 10.1136/heartjnl-2018-313242
    PubMed     Abstract available

  155. AZEVEDO CF, Bittencourt MS
    Can coronary computed tomography angiography be the complete roadmap for chronic total occlusion management?
    Heart. 2018 Sep 4. pii: heartjnl-2018-313773. doi: 10.1136/heartjnl-2018-313773.

  156. OTTO CM
    Heartbeat: Social isolation is associated with increased mortality after acute myocardial infarction or stroke.
    Heart. 2018;104:1471-1473.

  157. OTTO CM
    Heartbeat: The ongoing controversy of intervention for chronic total coronary occlusions.
    Heart. 2018;104:1385-1387.

  158. DIBBEN GO, Dalal HM, Taylor RS, Doherty P, et al
    Cardiac rehabilitation and physical activity: systematic review and meta-analysis.
    Heart. 2018;104:1394-1402.
    PubMed     Abstract available

  159. LODI-JUNQUEIRA L, Ribeiro AL
    Tackling acute coronary syndrome in low-income and middle-income countries.
    Heart. 2018;104:1390-1391.

  160. SIDHARTA SL, Baillie TJ, Howell S, Nicholls SJ, et al
    Evaluation of human coronary vasodilator function predicts future coronary atheroma progression.
    Heart. 2018;104:1439-1446.
    PubMed     Abstract available

  161. GALAPPATTHY P, Bataduwaarachchi VR, Ranasinghe P, Galappatthy GKS, et al
    Management, characteristics and outcomes of patients with acute coronary syndrome in Sri Lanka.
    Heart. 2018;104:1424-1431.
    PubMed     Abstract available

    August 2018
  162. SANTO K, Singleton A, Rogers K, Thiagalingam A, et al
    Medication reminder applications to improve adherence in coronary heart disease: a randomised clinical trial.
    Heart. 2018 Aug 27. pii: heartjnl-2018-313479. doi: 10.1136/heartjnl-2018-313479
    PubMed     Abstract available

  163. Correction: Twenty-five-year trends in myocardial infarction attack and mortality rates, and case-fatality, in six European populations.
    Heart. 2018;104:e2.

  164. HUTCHINGS DC, Anderson SG, Caldwell JL, Trafford AW, et al
    Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?
    Heart. 2018;104:1244-1250.
    PubMed     Abstract available

    July 2018
  165. OPOLSKI MP, Gransar H, Lu Y, Achenbach S, et al
    Prognostic value of chronic total occlusions detected on coronary computed tomographic angiography.
    Heart. 2018 Jul 30. pii: heartjnl-2017-312907. doi: 10.1136/heartjnl-2017-312907
    PubMed     Abstract available

  166. KUMAR N
    Does the purported mortality benefit of beta-blocker therapy in heart failure with a preserved ejection fraction apply to patients without prior myocardial infarction?
    Heart. 2018;104:1135.

  167. COENEN P
    Preventing disease by integrating physical activity in clinical practice: what works for whom?
    Heart. 2018;104:1140-1141.

  168. PETERS SA, Woodward M
    Women's reproductive factors and incident cardiovascular disease in the UK Biobank.
    Heart. 2018;104:1069-1075.
    PubMed     Abstract available

  169. NAKAO YM, Miyamoto Y, Higashi M, Noguchi T, et al
    Sex differences in impact of coronary artery calcification to predict coronary artery disease.
    Heart. 2018;104:1118-1124.
    PubMed     Abstract available

  170. JARVIE JL, Metz TD, Davis MB, Ehrig JC, et al
    Short-term risk of cardiovascular readmission following a hypertensive disorder of pregnancy.
    Heart. 2018;104:1187-1194.
    PubMed     Abstract available

    June 2018
  171. FAHEY JK, Ihdayhid AR, White AJ
    A 42-year-old woman with acute myocardial infarction.
    Heart. 2018 Jun 28. pii: heartjnl-2017-312779. doi: 10.1136/heartjnl-2017-312779

  172. WINTHER S, Nissen L, Schmidt SE, Westra JS, et al
    Diagnostic performance of an acoustic-based system for coronary artery disease risk stratification.
    Heart. 2018;104:928-935.
    PubMed     Abstract available

  173. ZHU K, Knuiman M, Divitini M, Murray K, et al
    High-sensitivity cardiac troponin I and risk of cardiovascular disease in an Australianpopulation-based cohort.
    Heart. 2018;104:895-903.
    PubMed     Abstract available

    May 2018
  174. DOCHERTY KF, Jhund PS
    Early use of mineralocorticoid receptor antagonists in ST-elevation myocardial infarction: is it ever too early?
    Heart. 2018 May 14. pii: heartjnl-2018-313371. doi: 10.1136/heartjnl-2018-313371

  175. KANDAN SR, Johnson TW
    Management of percutaneous coronary intervention complications.
    Heart. 2018 May 14. pii: heartjnl-2017-311155. doi: 10.1136/heartjnl-2017-311155

  176. VANEZIS AP, Arnold JR, Rodrigo G, Lai FY, et al
    Daily remote ischaemic conditioning following acute myocardial infarction: a randomised controlled trial.
    Heart. 2018 May 10. pii: heartjnl-2018-313091. doi: 10.1136/heartjnl-2018-313091
    PubMed     Abstract available

    April 2018
  177. BEYGUI F, Van Belle E, Ecollan P, Machecourt J, et al
    Individual participant data analysis of two trials on aldosterone blockade in myocardial infarction.
    Heart. 2018 Apr 25. pii: heartjnl-2018-312950. doi: 10.1136/heartjnl-2018-312950
    PubMed     Abstract available

  178. NIJJER SS
    Clinical outcomes of potent antiplatelets compared with clopidogrel in ST elevation myocardial infarction.
    Heart. 2018 Apr 17. pii: heartjnl-2018-312967. doi: 10.1136/heartjnl-2018-312967

  179. MUNDAL LJ, Igland J, Veierod MB, Holven KB, et al
    Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia.
    Heart. 2018 Apr 5. pii: heartjnl-2017-312706. doi: 10.1136/heartjnl-2017-312706.
    PubMed     Abstract available

  180. OTTO CM
    Heartbeat: Acute myocardial infarction: one test to diagnose them all?
    Heart. 2018;104:625-627.

  181. CHAPMAN AR, Mills NL
    A single blood test to rule out acute coronary syndrome.
    Heart. 2018;104:632-633.

  182. GIANNAKOULAS G, Ntiloudi D
    Acquired cardiovascular disease in adult patients with congenital heart disease.
    Heart. 2018;104:546-547.

  183. WILLIAMS MC, Shambrook J, Nicol ED
    Assessment of patients with stable chest pain.
    Heart. 2018;104:691-699.

  184. LEE KK, Welton N, Shah AS, Adamson PD, et al
    Differences in relative and absolute effectiveness of oral P2Y 12 inhibition in men and women: a meta-analysis and modelling study.
    Heart. 2018;104:657-664.
    PubMed     Abstract available

  185. CARLTON EW, Pickering JW, Greenslade J, Cullen L, et al
    Assessment of the 2016 National Institute for Health and Care Excellence high-sensitivity troponin rule-out strategy.
    Heart. 2018;104:665-672.
    PubMed     Abstract available

    March 2018
  186. ENGSTROM T, Nepper-Christensen L, Helqvist S, Klovgaard L, et al
    Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial.
    Heart. 2018 Mar 30. pii: heartjnl-2017-312774. doi: 10.1136/heartjnl-2017-312774
    PubMed     Abstract available

  187. JOHNSTONE SR, Isakson BE
    'Gaps' in targeted ischaemic injury therapies in ST-elevation myocardial infarction.
    Heart. 2018 Mar 30. pii: heartjnl-2018-313084. doi: 10.1136/heartjnl-2018-313084

  188. SEPEHRVAND N, James SK, Stub D, Khoshnood A, et al
    Effects of supplemental oxygen therapy in patients with suspected acute myocardial infarction: a meta-analysis of randomised clinical trials.
    Heart. 2018 Mar 29. pii: heartjnl-2018-313089. doi: 10.1136/heartjnl-2018-313089
    PubMed     Abstract available

  189. HAKULINEN C, Pulkki-Raback L, Virtanen M, Jokela M, et al
    Social isolation and loneliness as risk factors for myocardial infarction, stroke and mortality: UK Biobank cohort study of 479 054 men and women.
    Heart. 2018 Mar 27. pii: heartjnl-2017-312663. doi: 10.1136/heartjnl-2017-312663
    PubMed     Abstract available

  190. EDFORS R, Sahlen A, Szummer K, Renlund H, et al
    Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function.
    Heart. 2018 Mar 24. pii: heartjnl-2017-312436. doi: 10.1136/heartjnl-2017-312436
    PubMed     Abstract available

  191. GRIMALDI-BENSOUDA L, Danchin N, Dallongeville J, Falissard B, et al
    Effectiveness of new antiplatelets in the prevention of recurrent myocardial infarction.
    Heart. 2018 Mar 13. pii: heartjnl-2017-312534. doi: 10.1136/heartjnl-2017-312534
    PubMed     Abstract available

  192. OTTO CM
    Heartbeat: Is there any effective therapy for heart failure with preserved ejection fraction?
    Heart. 2018;104:361-362.

  193. SUNAMURA M, Ter Hoeve N, van den Berg-Emons RJG, Geleijnse ML, et al
    Randomised controlled trial of two advanced and extended cardiac rehabilitation programmes.
    Heart. 2018;104:430-437.
    PubMed     Abstract available

    Rotational atherectomy: re-emergence of an old technique.
    Heart. 2018;104:440-448.

  195. STOJKOVIC S, Milasinovic D
    Chronic total occlusion percutaneous coronary intervention in clinical practice: novel grounds to be EXPLOREd.
    Heart. 2018 Mar 1. pii: heartjnl-2018-312940. doi: 10.1136/heartjnl-2018-312940.

    February 2018
  196. LAMPREA-MONTEALEGRE JA, McClelland RL, Grams M, Ouyang P, et al
    Coronary heart disease risk associated with the dyslipidaemia of chronic kidney disease.
    Heart. 2018 Feb 22. pii: heartjnl-2017-312794. doi: 10.1136/heartjnl-2017-312794
    PubMed     Abstract available

  197. ELIAS J, van Dongen IM, Ramunddal T, Laanmets P, et al
    Long-term impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction.
    Heart. 2018 Feb 20. pii: heartjnl-2017-312698. doi: 10.1136/heartjnl-2017-312698
    PubMed     Abstract available

  198. GARD A, Lindahl B, Batra G, Hadziosmanovic N, et al
    Interphysician agreement on subclassification of myocardial infarction.
    Heart. 2018 Feb 16. pii: heartjnl-2017-312409. doi: 10.1136/heartjnl-2017-312409
    PubMed     Abstract available

  199. FERRARIO MM, Roncaioli M, Veronesi G, Holtermann A, et al
    Differing associations for sport versus occupational physical activity and cardiovascular risk.
    Heart. 2018 Feb 9. pii: heartjnl-2017-312594. doi: 10.1136/heartjnl-2017-312594.
    PubMed     Abstract available

  200. BRAVO CA, Hirji SA, Bhatt DL, Gluud C, et al
    Cochrane corner: complete versus culprit-only revascularisation in ST segment elevation myocardial infarction with multivessel disease.
    Heart. 2018 Feb 8. pii: heartjnl-2017-312857. doi: 10.1136/heartjnl-2017-312857.

  201. FOO CY, Bonsu KO, Nallamothu BK, Reid CM, et al
    Coronary intervention door-to-balloon time and outcomes in ST-elevation myocardial infarction: a meta-analysis.
    Heart. 2018 Feb 5. pii: heartjnl-2017-312517. doi: 10.1136/heartjnl-2017-312517.
    PubMed     Abstract available

  202. OLIER I, Sirker A, Hildick-Smith DJR, Kinnaird T, et al
    Association of different antiplatelet therapies with mortality after primary percutaneous coronary intervention.
    Heart. 2018 Feb 2. pii: heartjnl-2017-312366. doi: 10.1136/heartjnl-2017-312366.
    PubMed     Abstract available

  203. OTTO CM
    Heartbeat: Computed tomographic coronary angiography in patients with possible angina.
    Heart. 2018;104:183-185.

  204. GONGORA CA, Bavishi C, Uretsky S, Argulian E, et al
    Acute chest pain evaluation using coronary computed tomography angiography compared with standard of care: a meta-analysis of randomised clinical trials.
    Heart. 2018;104:215-221.
    PubMed     Abstract available

  205. ADAMSON PD, Hunter A, Williams MC, Shah ASV, et al
    Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial.
    Heart. 2018;104:207-214.
    PubMed     Abstract available

  206. OTTO CM
    Heartbeat: Transcatheter procedures for secondary mitral regurgitation?
    Heart. 2018;104:275-277.

  207. FORD TJ, Corcoran D, Berry C
    Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need.
    Heart. 2018;104:284-292.
    PubMed     Abstract available

  208. WANG M, Vaez M, Dorner TE, Tiihonen J, et al
    Trajectories and characteristics of work disability before and after acute myocardial infarction.
    Heart. 2018;104:340-348.
    PubMed     Abstract available

  209. ICHIKAWA K, Sakuragi S, Nishihara T, Tsuji M, et al
    Influence of arterial stiffness on cardiovascular outcome in patients without high blood pressure.
    Heart. 2018;104:318-323.
    PubMed     Abstract available

    January 2018
  210. SMILOWITZ NR, Gupta N, Guo Y, Beckman JA, et al
    Trends in cardiovascular risk factor and disease prevalence in patients undergoing non-cardiac surgery.
    Heart. 2018 Jan 5. pii: heartjnl-2017-312391. doi: 10.1136/heartjnl-2017-312391.
    PubMed     Abstract available

  211. SINGH D, Bhat R, Kothari SS
    25-year-old man with chest pain.
    Heart. 2018;104:72.
    PubMed     Abstract available

  212. MURPHY A, Johnson CO, Roth GA, Forouzanfar MH, et al
    Ischaemic heart disease in the former Soviet Union 1990-2015 according to the Global Burden of Disease 2015 Study.
    Heart. 2018;104:58-66.
    PubMed     Abstract available

  213. GREY C, Jackson R, Wells S, Wu B, et al
    First and recurrent ischaemic heart disease events continue to decline in New Zealand, 2005-2015.
    Heart. 2018;104:51-57.
    PubMed     Abstract available

  214. ARRI SS, Patterson T, Williams RP, Moschonas K, et al
    Myocardial revascularisation in high-risk subjects.
    Heart. 2018;104:166-179.

  215. BAENA-DIEZ JM, Garcia-Gil M, Comas-Cufi M, Ramos R, et al
    Association between chronic immune-mediated inflammatory diseases and cardiovascular risk.
    Heart. 2018;104:119-126.
    PubMed     Abstract available

  216. MAZNYCZKA AM, McCartney P, Berry C
    Reference invasive tests of microvascular injury in myocardial infarction.
    Heart. 2018;104:90-92.

  217. DE WAARD GA, Fahrni G, de Wit D, Kitabata H, et al
    Hyperaemic microvascular resistance predicts clinical outcome and microvascular injury after myocardial infarction.
    Heart. 2018;104:127-134.
    PubMed     Abstract available

    December 2017
  218. STEWART RAH, Colquhoun DM, Marschner SL, Kirby AC, et al
    Persistent psychological distress and mortality in patients with stable coronary artery disease.
    Heart. 2017;103:1860-1866.
    PubMed     Abstract available

  219. ROUX V, Salaun E, Tribouilloy C, Hubert S, et al
    Coronary events complicating infective endocarditis.
    Heart. 2017;103:1906-1910.
    PubMed     Abstract available

  220. GNANENTHIRAN SR, Kritharides L, D'Souza M, Lowe HC, et al
    Revascularisation compared with initial medical therapy for non-ST-elevation acute coronary syndromes in the elderly: a meta-analysis.
    Heart. 2017;103:1962-1969.
    PubMed     Abstract available

  221. DE CARLO M, Liga R
    Elderly patients with non-ST-elevation acute coronary syndromes: a call for action.
    Heart. 2017;103:1932-1933.

  222. SAINSBURY PA, Fisher M, de Silva R
    Alternative interventions for refractory angina.
    Heart. 2017;103:1911-1922.

    November 2017
  223. KIM TH, Kim H, Kim IC, Yoon HJ, et al
    Heart rate at first postdischarge visit and outcomes in patients with heart failure.
    Heart. 2017 Nov 25. pii: heartjnl-2017-312364. doi: 10.1136/heartjnl-2017-312364
    PubMed     Abstract available

  224. MOTWANI M, Swoboda PP, Plein S, Greenwood JP, et al
    Role of cardiovascular magnetic resonance in the management of patients with stable coronary artery disease.
    Heart. 2017 Nov 23. pii: heartjnl-2017-311658. doi: 10.1136/heartjnl-2017-311658
    PubMed     Abstract available

  225. DURKO AP, Budde RPJ, Geleijnse ML, Kappetein AP, et al
    Recognition, assessment and management of the mechanical complications of acute myocardial infarction.
    Heart. 2017 Nov 16. pii: heartjnl-2017-311473. doi: 10.1136/heartjnl-2017-311473

  226. TOYOTA T, Morimoto T, Shiomi H, Yamaji K, et al
    Single-session versus staged procedures for elective multivessel percutaneous coronary intervention.
    Heart. 2017 Nov 16. pii: heartjnl-2017-312117. doi: 10.1136/heartjnl-2017-312117
    PubMed     Abstract available

  227. DREISBACH JG, Nicol ED, Roobottom CA, Padley S, et al
    Challenges in delivering computed tomography coronary angiography as the first-line test for stable chest pain.
    Heart. 2017 Nov 14. pii: heartjnl-2017-311846. doi: 10.1136/heartjnl-2017-311846
    PubMed     Abstract available

  228. MANGION K, Gao H, Husmeier D, Luo X, et al
    Advances in computational modelling for personalised medicine after myocardial infarction.
    Heart. 2017 Nov 10. pii: heartjnl-2017-311449. doi: 10.1136/heartjnl-2017-311449
    PubMed     Abstract available

  229. BAI L, Li Q, Wang J, Lavigne E, et al
    Increased coronary heart disease and stroke hospitalisations from ambient temperatures in Ontario.
    Heart. 2017 Nov 3. pii: heartjnl-2017-311821. doi: 10.1136/heartjnl-2017-311821.
    PubMed     Abstract available

  230. MATULEVICIENE-ANANGEN V, Rosengren A, Svensson AM, Pivodic A, et al
    Glycaemic control and excess risk of major coronary events in persons with type 1 diabetes.
    Heart. 2017;103:1687-1695.
    PubMed     Abstract available

  231. HOORWEG BB, Willemsen RT, Cleef LE, Boogaerts T, et al
    Frequency of chest pain in primary care, diagnostic tests performed and final diagnoses.
    Heart. 2017;103:1727-1732.
    PubMed     Abstract available

  232. GRAY AM, Murphy J, Altman DG, Benedetto U, et al
    One-year costs of bilateral or single internal mammary grafts in the Arterial Revascularisation Trial.
    Heart. 2017;103:1719-1726.
    PubMed     Abstract available

  233. SILVAIN J, Nguyen LS, Spagnoli V, Kerneis M, et al
    Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Heart. 2017 Nov 1. pii: heartjnl-2017-311975. doi: 10.1136/heartjnl-2017-311975.
    PubMed     Abstract available

  234. DENBY KJ, Clark DE, Markham LW
    Management of Kawasaki disease in adults.
    Heart. 2017;103:1760-1769.
    PubMed     Abstract available

  235. HERRINGTON WG, Bragg F
    Extreme ischaemic heart disease risk in people with type 1 diabetes.
    Heart. 2017;103:1656-1657.

  236. RAHIMI K, Otto CM
    Heartbeat: Glycaemic control and excess risk of major coronary events in type 1 diabetes.
    Heart. 2017;103:1653-1655.

  237. SINDET-PEDERSEN C, Staerk L, Lamberts M, Gerds TA, et al
    Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation.
    Heart. 2017 Nov 1. pii: heartjnl-2017-311976. doi: 10.1136/heartjnl-2017-311976.
    PubMed     Abstract available

    October 2017
  238. DE MARIA GL, Patel N, Banning AP
    Obstructive left main stem coronary disease: is it time to recommend coronary stenting?
    Heart. 2017 Oct 23. pii: heartjnl-2016-310880. doi: 10.1136/heartjnl-2016-310880

  239. CORTIGIANI L, Carpeggiani C, Sicari R, Michelassi C, et al
    Simple six-item clinical score improves risk prediction capability of stress echocardiography.
    Heart. 2017 Oct 14. pii: heartjnl-2017-312122. doi: 10.1136/heartjnl-2017-312122
    PubMed     Abstract available

  240. WANG N, Fulcher J, Abeysuriya N, Adams M, et al
    Predictors of successful chronic total occlusion percutaneous coronary interventions: a systematic review and meta-analysis.
    Heart. 2017 Oct 6. pii: heartjnl-2017-311986. doi: 10.1136/heartjnl-2017-311986.
    PubMed     Abstract available

  241. OTTO CM
    Heartbeat: Virtual histopathology after myocardial infarction.
    Heart. 2017;103:1473-1474.

  242. OTTO CM
    Heartbeat: Ischemic heart disease risk factors in women.
    Heart. 2017;103:1559-1561.

  243. ASHER E, Kogan A, Segev A
    Severe upper abdominal pain in a 43-year-old woman.
    Heart. 2017;103:1650.
    PubMed     Abstract available

  244. MADONIS SM, Skelding KA, Roberts M
    Management of acute coronary syndromes: special considerations in women.
    Heart. 2017;103:1638-1646.

    September 2017
  245. ZHAO M, Vaartjes I, Graham I, Grobbee D, et al
    Sex differences in risk factor management of coronary heart disease across three regions.
    Heart. 2017 Sep 20. pii: heartjnl-2017-311429. doi: 10.1136/heartjnl-2017-311429
    PubMed     Abstract available

  246. ALBADRI A, Wei J, Mehta PK, Shah R, et al
    Sex differences in coronary heart disease risk factors: rename it ischaemic heart disease!
    Heart. 2017 Sep 20. pii: heartjnl-2017-311921. doi: 10.1136/heartjnl-2017-311921

  247. PICCOLO R, Franzone A, Windecker S
    From bare metal to barely anything: an update on coronary stenting.
    Heart. 2017 Sep 19. pii: heartjnl-2016-310877. doi: 10.1136/heartjnl-2016-310877

    August 2017
  248. BOKMA JP, Zegstroo I, Kuijpers JM, Konings TC, et al
    Factors associated with coronary artery disease and stroke in adults with congenital heart disease.
    Heart. 2017 Aug 28. pii: heartjnl-2017-311620. doi: 10.1136/heartjnl-2017-311620
    PubMed     Abstract available

  249. FERREIRA JP, Rossignol P, Demissei B, Sharma A, et al
    Coronary angiography in worsening heart failure: determinants, findings and prognostic implications.
    Heart. 2017 Aug 10. pii: heartjnl-2017-311750. doi: 10.1136/heartjnl-2017-311750
    PubMed     Abstract available

  250. WILSON S, Newby DE
    Predicting long-term bleeding risk after acute coronary syndrome: a step closer to optimising dual antiplatelet therapy duration?
    Heart. 2017;103:1143-1145.

    July 2017
  251. TIMMIS A, Roobottom C
    Re: The National Institute for Health and Care Excellence update for stable chest pain: poorly reasoned and risky for patients.
    Heart. 2017;103:1055.

  252. BRUGALETTA S, Sabate M
    A longer look at trial evidence of bioresorbable vascular scaffolds.
    Heart. 2017;103:1061-1062.

  253. OTTO CM, Luiz Ribeiro A
    Heartbeat: Anatomy versus physiology for diagnosis of coronary artery disease.
    Heart. 2017;103:969-971.

    June 2017
  254. FISHER SA, Doree C, Mathur A, Taggart DP, et al
    Cochrane Corner: stem cell therapy for chronic ischaemic heart disease and congestive heart failure.
    Heart. 2017 Jun 12. pii: heartjnl-2017-311684. doi: 10.1136/heartjnl-2017-311684

  255. MOSS AJ, Lim KH, Japp AG
    A 49-year-old with chest pain and collapse.
    Heart. 2017;103:968.

    May 2017
  256. RAJANI R, Modi B, Ntalas I, Curzen N, et al
    Non-invasive Fractional Flow Reserve using Computed Tomographic angiography: where are we now and where are we going?
    Heart. 2017 May 30. pii: heartjnl-2016-311029. doi: 10.1136/heartjnl-2016-311029

    April 2017
  257. CADEMARTIRI F, Nistri S, Tarantini G, Maffei E, et al
    Management of coronary artery disease with cardiac CT beyond gatekeeping.
    Heart. 2017 Apr 26. pii: heartjnl-2016-310473. doi: 10.1136/heartjnl-2016-310473

  258. THOMPSON LE, Daugherty SL
    Gender disparities in cardiovascular disease prevention.
    Heart. 2017;103:479-480.

  259. DE SILVA K, Myat A, Cotton J, James S, et al
    Bleeding associated with the management of acute coronary syndromes.
    Heart. 2017;103:546-562.

    January 2017
  260. CASSESE S, Xhepa E, Kastrati A
    Biodegradable-polymer drug-eluting stents: back to the future?
    Heart. 2017;103:91-92.

  261. GIAVARINI A, Kilic ID, Redondo Dieguez A, Longo G, et al
    Intracoronary Imaging.
    Heart. 2017 Jan 5. pii: heartjnl-2015-307888. doi: 10.1136/heartjnl-2015-307888.

    November 2016
  262. EISEN A, Bhatt DL
    Optimal duration of dual antiplatelet therapy after acute coronary syndromes and coronary stenting.
    Heart. 2016 Nov 25. pii: heartjnl-2015-309022. doi: 10.1136/heartjnl-2015-309022

    September 2016
  263. COCKBURN J, Hildick-Smith D, Trivedi U, de Belder A, et al
    Coronary revascularisation in the elderly.
    Heart. 2016 Sep 14. pii: heartjnl-2015-308999. doi: 10.1136/heartjnl-2015-308999

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.